Raltegravir Tablets

Raltegravir Tablets Impurities & Reference Standards

Raltegravir Tablets is an established active pharmaceutical ingredient (API) with broad application in pharmaceutical formulation, drug substance manufacturing, and quality control. Raltegravir Tablets related substances / impurity reference standards support HPLC method validation, forced degradation studies, and regulatory documentation consistent with ICH, USP, BP, and EP requirements. Each batch of Raltegravir Tablets reference standard is accompanied by a Certificate of Analysis (CoA), HPLC purity data, and spectroscopic (NMR/MS/IR) characterization for use in pharmaceutical laboratories worldwide.